Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis

B. Stegmayr, E. Newman, V. Witt, K. Derfler, G. Leitner, S. Eloot, A. Dhondt, D. Deeren, J. Ptak, M. Blaha, M. Lanska, Z. Gasova, Z. Bhuiyan-Ludvikova, R. Hrdlickova, W. Ramlow, H. Prophet, JT. Kielstein, G. Liumbruno, E. Mori, A. Griskevicius,...

. 2021 ; 48 (4) : 234-239. [pub] 20210105

Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc21024257

Therapeutic apheresis (TA) is prescribed to patients that suffer from a severe progressive disease that is not sufficiently treated by conventional medications. A way to gain more knowledge about this treatment is usually by the local analysis of data. However, the use of large quality assessment registries enables analyses of even rare findings. Here, we report some of the recent data from the World Apheresis Association (WAA) registry. Data from >104,000 procedures were documented, and TA was performed on >15,000 patients. The main indication for TA was the collection of autologous stem cells (45% of patients) as part of therapy for therapy. Collection of stem cells from donors for allogeneic transplantation was performed in 11% of patients. Patients with indications such as neurological diseases underwent plasma exchange (28%). Extracorporeal photochemotherapy, lipid apheresis, and antibody removal were other indications. Side effects recorded in the registry have decreased significantly over the years, with approximately only 10/10,000 procedures being interrupted for medical reasons.Conclusion: Collection of data from TA procedures within a multinational and multicenter concept facilitates the improvement of treatment by enabling the analysis of and feedback on indications, procedures, effects, and side effects.

Apheresis Center North Rostock Germany

Apheresis Center University Hospital Lund Sweden

Apheresis Center University Hospital Orebro Sweden

Apheresis Unit Coimbra University Hospital Coimbra Portugal

Apheresis Unit Haematological AKH Vienna Austria

Apheresis Unit Renal AKH Vienna Austria

Apheresis Unit University Hospital Ostrava Czechia

Banc de Sang i Teixits Hospital Bellvitge Barcelona Spain

Blood Center Livorno Italy

Blood Center University Uppsala Sweden Uppsala Sweden

Bone Marrow Transplant and Apheresis Concord New South Wales Australia

Center for Immunology and Transfusion Akers University Hospital Loerenskog Norway

Clinical Immunology and Transfusion Medicine Linköping University Linköping Sweden

Department Haematology University Hospital Ankara Turkey

Department of Hematology AZ Delta Roeselare Belgium

Department of Nephrology Karlstad Sweden

Department of Nephrology Skaraborg Hospital Skövde Sweden

Department of Nephrology University Hospital Ghent Belgium

Department of Nephrology University Hospital Huddinge Sweden

Department of Nephrology University Hospital Skopje North Macedonia

Department of Nephrology University Hospital Uppsala Sweden

Hemapheretic Center of the 3rd Department of Medicine Medical Faculty and University Hospital Hradec Kralove Czechia

Institute for Endocrinology University Hospital Belgrade Serbia

Institute of Hematology and Blood Transfusion Prague Czechia

Italian National Blood Centre National Institute of Health Rome Italy

Nephrology Rheumatology Blood Purification Academic Teaching Hospital Braunschweig Germany

Public Health and Clinical Medicine Umeå University Umeå Sweden

Sanquin Blood Supply Amsterdam The Netherlands

South African National Blood Service Johannesburg South Africa

St Anna Pediatric Department Vienna Austria

Therapeutic Apheresis Unit University Hospital Vilnius Lithuania

Transfusion Medicine and Transplantation Biology University Zagreb Croatia

Transfusion Medicine Frydek Mistek Czechia

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024257
003      
CZ-PrNML
005      
20211013134010.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000513123 $2 doi
035    __
$a (PubMed)34539317
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Stegmayr, Bernd $u Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
245    10
$a Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis / $c B. Stegmayr, E. Newman, V. Witt, K. Derfler, G. Leitner, S. Eloot, A. Dhondt, D. Deeren, J. Ptak, M. Blaha, M. Lanska, Z. Gasova, Z. Bhuiyan-Ludvikova, R. Hrdlickova, W. Ramlow, H. Prophet, JT. Kielstein, G. Liumbruno, E. Mori, A. Griskevicius, J. Audzijoniene, H. Vrielink, E. Rombout-Sestrienkova, A. Aandahl, A. Sikole, J. Tomaz, K. Lalic, I. Bojanic, V. Strineholm, B. Brink, G. Berlin, J. Dykes, T. Nilsson, T. Eich, H. Hadimeri, G. Welander, S. Ortega Sanchez, O. Ilhan, C. Poole
520    9_
$a Therapeutic apheresis (TA) is prescribed to patients that suffer from a severe progressive disease that is not sufficiently treated by conventional medications. A way to gain more knowledge about this treatment is usually by the local analysis of data. However, the use of large quality assessment registries enables analyses of even rare findings. Here, we report some of the recent data from the World Apheresis Association (WAA) registry. Data from >104,000 procedures were documented, and TA was performed on >15,000 patients. The main indication for TA was the collection of autologous stem cells (45% of patients) as part of therapy for therapy. Collection of stem cells from donors for allogeneic transplantation was performed in 11% of patients. Patients with indications such as neurological diseases underwent plasma exchange (28%). Extracorporeal photochemotherapy, lipid apheresis, and antibody removal were other indications. Side effects recorded in the registry have decreased significantly over the years, with approximately only 10/10,000 procedures being interrupted for medical reasons.Conclusion: Collection of data from TA procedures within a multinational and multicenter concept facilitates the improvement of treatment by enabling the analysis of and feedback on indications, procedures, effects, and side effects.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Newman, Elizabeth $u Bone Marrow Transplant and Apheresis, Concord, New South Wales, Australia
700    1_
$a Witt, Volker $u St. Anna, Pediatric Department, Vienna, Austria
700    1_
$a Derfler, Kurt $u Apheresis Unit, Renal, AKH, Vienna, Austria
700    1_
$a Leitner, Gerda $u Apheresis Unit, Haematological, AKH, Vienna, Austria
700    1_
$a Eloot, Sunny $u Department of Nephrology, University Hospital, Ghent, Belgium
700    1_
$a Dhondt, Annemieke $u Department of Nephrology, University Hospital, Ghent, Belgium
700    1_
$a Deeren, Dries $u Department of Hematology, AZ Delta, Roeselare, Belgium
700    1_
$a Ptak, Jan $u Transfusion Medicine, Frydek-Mistek, Czechia
700    1_
$a Blaha, Milan $u Hemapheretic Center of the 3rd Department of Medicine, Medical Faculty and University Hospital, Hradec Kralove, Czechia
700    1_
$a Lanska, Mirka $u Hemapheretic Center of the 3rd Department of Medicine, Medical Faculty and University Hospital, Hradec Kralove, Czechia
700    1_
$a Gasova, Zdenka $u Institute of Hematology and Blood Transfusion, Prague, Czechia
700    1_
$a Bhuiyan-Ludvikova, Zdenka $u Institute of Hematology and Blood Transfusion, Prague, Czechia
700    1_
$a Hrdlickova, Radomira $u Apheresis Unit, University Hospital, Ostrava, Czechia
700    1_
$a Ramlow, Wolfgang $u Apheresis Center North, Rostock, Germany
700    1_
$a Prophet, Heinrich $u Apheresis Center North, Rostock, Germany
700    1_
$a Kielstein, Jan T $u Nephrology, Rheumatology, Blood Purification, Academic Teaching Hospital, Braunschweig, Germany
700    1_
$a Liumbruno, Giancarlo $u Italian National Blood Centre, National Institute of Health, Rome, Italy
700    1_
$a Mori, Elena $u Blood Center, Livorno, Italy
700    1_
$a Griskevicius, Antanas $u Therapeutic Apheresis Unit, University Hospital, Vilnius, Lithuania
700    1_
$a Audzijoniene, Judita $u Therapeutic Apheresis Unit, University Hospital, Vilnius, Lithuania
700    1_
$a Vrielink, Hans $u Sanquin Blood Supply, Amsterdam, The Netherlands
700    1_
$a Rombout-Sestrienkova, Eva $u Sanquin Blood Supply, Amsterdam, The Netherlands
700    1_
$a Aandahl, Astrid $u Center for Immunology and Transfusion, Akers University Hospital, Loerenskog, Norway
700    1_
$a Sikole, Aleksandar $u Department of Nephrology, University Hospital, Skopje, North Macedonia
700    1_
$a Tomaz, Jorge $u Apheresis Unit, Coimbra University Hospital, Coimbra, Portugal
700    1_
$a Lalic, Katarina $u Institute for Endocrinology, University Hospital, Belgrade, Serbia
700    1_
$a Bojanic, Ines $u Transfusion Medicine and Transplantation Biology, University, Zagreb, Croatia
700    1_
$a Strineholm, Virginia $u Apheresis Center, University Hospital, Orebro, Sweden
700    1_
$a Brink, Bo $u Department of Nephrology, University Hospital, Huddinge, Sweden
700    1_
$a Berlin, Gösta $u Clinical Immunology and Transfusion Medicine, Linköping University, Linköping, Sweden
700    1_
$a Dykes, Josefina $u Apheresis Center, University Hospital, Lund, Sweden
700    1_
$a Nilsson, Thomas $u Department of Nephrology, University Hospital, Uppsala, Sweden
700    1_
$a Eich, Torsten $u Blood Center, University, Uppsala, Sweden, Uppsala, Sweden
700    1_
$a Hadimeri, Henrik $u Department of Nephrology, Skaraborg Hospital, Skövde, Sweden
700    1_
$a Welander, Gunilla $u Department of Nephrology, Karlstad, Sweden
700    1_
$a Ortega Sanchez, Sandra $u Banc de Sang i Teixits, Hospital Bellvitge, Barcelona, Spain
700    1_
$a Ilhan, Osman $u Department Haematology, University Hospital, Ankara, Turkey
700    1_
$a Poole, Colwyn $u South African National Blood Service, Johannesburg, South Africa
773    0_
$w MED00007473 $t Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie $x 1660-3796 $g Roč. 48, č. 4 (2021), s. 234-239
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34539317 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013134007 $b ABA008
999    __
$a ind $b bmc $g 1708252 $s 1144754
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 48 $c 4 $d 234-239 $e 20210105 $i 1660-3796 $m Transfusion medicine and hemotherapy $n Transfus Med Hemother $x MED00007473
LZP    __
$a Pubmed-20211006

Find record

Citation metrics

Archiving options